1. Introduction {#sec1-molecules-23-01778}
===============

Meliaceae plants are a well-known source of structurally diverse limonoids with a wide range of bioactivities, such as antimalarial and antifeedant. Limonoids in the plant kingdom occur mainly in the Meliaceae, Rutaceae, and Simaroubaceae families \[[@B1-molecules-23-01778]\]. Andiroba is one of the Meliaceae plants in the rain forests of South America, and its woody four-cornered nut has four cells, each of which contains two to three seeds with oil-rich kernels. Limonoids, most of which are highly oxidized tetranortriterpenoids, can be classified in terms of *seco* form and cyclization patterns of rings A--D in the triterpene skeleton. Extracts from its flowers, bark, and seeds have been used for centuries by the Amazonian people and exhibit analgesic \[[@B2-molecules-23-01778]\], anti-malarial \[[@B3-molecules-23-01778]\], anti-inflammatory \[[@B4-molecules-23-01778]\], anti-allergic \[[@B5-molecules-23-01778]\], and anti-plasmoidal \[[@B6-molecules-23-01778]\] activities, and also acute and subacute toxicities \[[@B7-molecules-23-01778]\].

Our series of studies on the components of the seed oil of *C. guianensis* revealed the structures of carapanolides A and B \[[@B8-molecules-23-01778]\], guianolide A and B \[[@B9-molecules-23-01778]\], carapanolides C--I \[[@B10-molecules-23-01778]\], carapanolides J--L \[[@B11-molecules-23-01778]\], carapanolides M--S \[[@B12-molecules-23-01778]\], carapanolides T--X \[[@B13-molecules-23-01778]\], and carapanosins A--C \[[@B14-molecules-23-01778]\] in the seed oil of andiroba. Last year, we reported the absolute structure of guianolactones A and B from the seed oil of *C. guianasis* (Meliaceae) \[[@B15-molecules-23-01778]\]. Our recent study of the seed oil of *C. guianasis* revealed the structures of an unusual 19-*nor*-phragmalin-type limonoid, named carapanosin D and two novel mexicanolide-type limonoids, named carapanosins E and F. We herein describe the isolation and structural determination of three new limonoids and the effects of **1**--**3** on the production of nitric oxide (NO) in Lipopolysaccharide LPS-activated mouse peritoneal macrophages. The structures of **1**--**3** were determined on the basis of NMR spectroscopy, including one-dimensional (1D) and two-dimensional (2D) (^1^H, ^1^H-COSY, NOESY, HSQC, HMBC) NMR, and Fast Atom Bombardment (FABMS).

2. Results and Discussion {#sec2-molecules-23-01778}
=========================

The seeds of *Carapa guianensis* were dissolved in MeOH~,~ and the extract was separated by silica gel column chromatography (CC), medium-pressure liquid chromatography (MPLC), and reverse-phased HPLC to obtain three novel limonoids, **1**, **2**, and **3** ([Figure 1](#molecules-23-01778-f001){ref-type="fig"}).

Carapanosin D (**1**) was obtained as a colorless amorphous solid, and possesses a molecular formula of C~37~H~44~O~16~ (*m*/*z* 745.2693 \[M + H\]^+^, calcd. 745.2707) based on High resolution Fast Atom Bombardment Mass Spectrometry (HRFABMS). In accordance with the molecular formula, 16 degrees of unsaturation came from two carbon---carbon double bonds and six carbonyls; thus, the remaining eight degrees of unsaturation indicated **1** to be octacyclic. The IR absorption implied the presence of several carbonyl groups (*ν*~max~ 1747 and 1633 cm^−1^). The ^1^H and ^13^C-NMR spectra ([Table 1](#molecules-23-01778-t001){ref-type="table"}) exhibited signals assignable to two tertiary methyls \[δ~H~ 0.98, 1.23 (each s)\]; three acetyls \[δ~H~ 1.96, 2.15, 2.30 (each 3H, s); δ~C~ 21.26, 21.33, 21.6 (each q), 169.3, 169.6, 172.0 (each s)\], a propanoyl \[δ~H~ 1.20 (3H, t), 2.26 (1H, m), 2.38 (1H, m); δ~C~ 21.3 (q), 28.0 (t), 172.0 (s)\], a methyl ester \[δ~H~ 3.69 (3H, s); δ~C~ 51.6 (q), 173.9 (s)\], an 1,8,9-orthoacetyl group \[δ~H~ 1.71 (3H, s), δ~C~ 20.6 (q), 84.0, 84.5, 85.3 (each s), 119.4 (s)\] \[[@B16-molecules-23-01778]\], four methylenes, five *sp*^3^ methines including three oxymethine \[δ~H~ 5.26 (s), δ~C~ 80.6 (d); 5.68 (s), δ~C~ 69.8 (d); 5.94 (s) δ~C~ 68.7 (d)\], six *sp*^3^ quaternary carbons including two oxycarbons \[δ~C~ 86.1 (d), 86.4 (s)\], a furan \[δ~H~ 6.40 (dd), 7.37 (t), 7.68 (brd)\], and a lactone \[δ~C~ 174.2 (s)\]. Analysis of the ^1^H-^1^H COSY spectrum of **1** revealed the partial structure shown in bold face in [Figure 2](#molecules-23-01778-f002){ref-type="fig"}. The HMBC connectivities between H~3~-18 \[δ~H~ 1.23 (s)\]/C-12, C-13, C-14 and C-17 \[δ~C~ 69.8 (d)\]; between H-3 \[δ~H~ 5.26 (s)\]/C-1 \[δ~C~ 84.6 (s)\], C-2 \[δ~C~ 86.1 (s)\], C-4, C-5, C-28, C-29, and C-30 \[δ~C~ 68.7 (d)\]; between H~2~-6 \[δ~H~ 2.52 (d)\], 2.68 (dd)\]/C-4, C-5, C-7 \[δ~C~ 174.2 (s)\], and C-10 \[δ~C~ 86.4 (s)\]; between H-14 \[δ~H~ 2.36 (dd)\]/C-8 \[ δ~C~ 85.3 (s)\], C-9 \[δ~C~ 84.0 (s)\], C-12, C-13, C-15, C-16 \[δ~C~ 173.9 (s)\], and C-30; between H-17 \[δ~H~ 5.68 (s) \] /C-12, C-13, C-14, C-20 \[δ~C~ 122.5 (s)\], C-21 \[δ~C~ 142.0 (d)\], and C-22 \[δ~C~ 109.2 (d)\]; between H~2~-29 \[δ~H~ 1.7 8 and 1.91 (each d)\]/C-1, C-2, C-3, C-4, C-5, and C-10; and between H-30 \[δ~H~ 5.94 (s)\]/C-2, C-3, C-8, C-9, C-1 4, and C-1′′′′′ \[δ~C~ 172.0 (s)\] were obtained ([Figure 2](#molecules-23-01778-f002){ref-type="fig"}).

The above NMR data of **1** were similar with those of andirolide O \[[@B17-molecules-23-01778]\], the exclusive difference being lack of C-19 methylene in carapanosin D (**1**), which was confirmed by the HMBC correlations from H~2~-6 and H~2~-29 to the deshielded oxycarbon C-10 \[δ~C~ 86.4 (s)\], respectively. Therefore **1** would be a 19-*nor* limonoid, and the E ring has a γ-lactone. On the other hand, C-16--C-17 was opened and attached to methylester and acetate, respectively. Thus, the framework of **1** could be a C-19-*nor*, C-16,17-*seco*-phragmalin-1,8,9-orthoacetate. The relative configuration of **1** was determined by the NOESY spectrum, in which significant nuclear Overhauser effect (NOE) were observed between H-3 and H~2~-29; between H-5 and H-12β, H-30, and CH~3~-28; between H-14 and H-11β; between H-17 and H-12β, H-30; between H-30 and H-5, H-12β, H-15β, and H-17; and between CH~3~-18 and H-11, H-12α, and H-22. Therefore, the relative structure of **1** was confirmed as shown in [Figure 1](#molecules-23-01778-f001){ref-type="fig"}. 19-*Nor*-phragmalin was first isolated from *Chukrasia tabularis* by Yin, J-L., et al., who described Tabulvelutin A as a unique 7,10-γ-lactone \[[@B18-molecules-23-01778]\], carapanosin D (**1**) is the second example of 19-*nor*-phragmalin.

Carapanosin E (**2**) was obtained as a colorless amorphous crystal, and has a molecular formula of C~36~H~48~O~12~ (*m*/*z* 673.3224 \[M + H\]^+^, calcd. 673.3224) by HRFABMS. The IR absorptions implied the presence of hydroxy, ester, six-membered ring ketone, and αβ-unsaturated δ-lactone at *ν*~max~ 3489, 1727, 1710, and 1670 cm^−1^. ^1^H and ^13^C-NMR spectra ([Table 2](#molecules-23-01778-t002){ref-type="table"}) revealed the presence of four methyls \[δ~H~ 0.83, 0.91, 1.09, 1.28 (each 3H, s)\], 2-methylpropanoyl \[δ~H~ 1.20 (3H, d), 1.27 (3H, d), 2.86 (1H, sept); δ~C~ 175.5 (s)\], 2-methylbutanoyl \[δ~H~ 0.87 (3H, t), 1.12 (3H, d), 1.46 m), 1.64 (1H, m), 2.43 (1H, m); δ~C~ 174.4 (s)\], a methylester \[δ~H~ 3.71 (3H, s); δ~C~ 52.3 (q), 173.8 (s)\], an αβ-unsaturated δ-lactone \[δ~H~ 6.34 (1H, s), δ~C~ 115.5 (d), 164.9 (s), 165.8 (s)\], a six-membered ring ketone \[δ~C~ 204.1 (s)\], two tertiary hydroxyls that disappear by heavy water processing \[δ~H~ 2.84, 4.08 (each 1H, s)\], and a β-substituted furan ring \[δ~H~ 6.47 (dd), 7.44 (t), 7.45 (d)\], therefore, **2** could be suggested as a mexicanolide-type limonoid. The HMBC connectivities between H~3~-18 \[δ~H~ 1.28 (s)\]/C-12, C-13, C-14 \[δ~C~ 165.8 (s)\], and C-17 \[δ~C~ 78.9 (d)\]; H~3~-19 \[δ~H~ 1.09 (s)\]/C-1 \[δ~C~ 204.1 (s)\], C-5, C-9, and C-10; H-3 \[δ~H~ 5.15 (s)\]/C-1, C-2 \[δ~C~ 86.3 (s)\], C-4, C-5, C-28, C-29, and C-30 \[δ~C~ 73.9 (d)\]; H-15 \[δ~H~ 6.34 (s)\]/C-8 \[δ~C~ 80.6 (s)\], C-13, C-14, and C-16 \[δ~C~ 164.9 (s)\]; H-17 \[δ~H~ 5.44 (s)\]/C-12, C-13, C-16, C-20 \[δ~C~ 120.3 (s)\], C-21 \[δ~C~ 141.6 (d)\], and C-22 \[δ~C~ 110.5 (d)\]; H-30 \[δ~H~ 6.51 (s)\]/C-1, C-2, C-3 \[δ~C~ 79.7 (s)\], C-8, C-9, and C-14; 2-O*H* (δ~H~ 4.08 (s)/C-1, C-2, and C-30; 8-O*H* (δ~H~ 2.84 (s)/C-8, C-9, C-14, and C-30 were observed. In the ^1^H-^1^H COSY spectrum, five distinct spin sets of H-5--H-6; H-9--H~2~-11--H~2~-12; H-22--H-23; H~3~-3′--H-2′--H~3~-4′; and H~3~′′′′-5--H-2′′′′--H~2~-3′′′′--H~3~-4′′′′ were observed ([Figure 3](#molecules-23-01778-f003){ref-type="fig"}). These results estimate the plain structure of **2** as shown in [Figure 3](#molecules-23-01778-f003){ref-type="fig"}. The relative configuration of **2** was mainly established by a NOESY experiment. It has strong cross-peaks of H~3~-18/H-9α, H-12α, H-15, H-21, and H-23; H~3~-19/H-6α, H-9α, H-11α, H~3~-29, and 2-OH; 8-OH/2- OH; H-3/H-6α, and H~3~-29, therefore, the relative structure was established as shown in [Figure 1](#molecules-23-01778-f001){ref-type="fig"}. The configuration of 2-methylbutanoyl group at C-30 was deduced to be *R* because the chemical shift value of Me-5'" \[δ~H~ 1.12 (d, *J* = 7.2 Hz); δ~C~ 16.7 (q)\] were in accordance with those of carapanolide F \[δ~H~ 1.02 (d, *J* = 7.2 Hz); δ~C~ 16.0 (q)\] \[[@B10-molecules-23-01778]\], which was determined as *R* by a single-crystal X-ray diffraction analysis.

Carapanosin F (**3**) has the molecular formula C~37~H~48~O~12~ (*m*/*z* 673.3224 \[M + H\]^+^, calcd. 673.3224) as determined by HRFABMS. The UV, IR spectra showed αβ-unsaturated δ-lactone and hydroxyl, ester, and a six-membered ring ketone \[UV λ~max~ (CH~3~CN) nm (log ε): 232 (3.82); IR ν~max~ cm^−1^ (KBr): 3462, 1727, 1707\]. NMR data were very similar to those of **2** except for a tigroyl group \[δ~H~ 1.91 (s), 1.92 (d), 6.88 (m); δ~C~ 12.4 (q), 14.7 (q), 128.8 (s), 138.2 (d)\] at C-3. NOESY spectrum revealed the relative stereochemistry of **3** to have the same conformation as **2**.

Physiological nitric oxide (NO) plays important roles in blood pressure regulation and blood flow distribution. However, its overexpression may cause multiple organ dysfunction, tissue injury, and systemic inflammatory responses in sepsis, such as hypotension, vascular hyporeactivity, and cardiodepression \[[@B19-molecules-23-01778]\]. In this study, three limonoids and N^G^-monomethyl-L-arginine acetate ([l]{.smallcaps}-NMMA), which is an inducible nitric oxide synthase (iNOS) inhibitor, were assayed for their inhibitory effects on NO production in LPS stimulated RAW 264.7 cells. Cytotoxicities of limonoids tested were evaluated by the \[3-(4,5-dimethylthial-2-yl)-2,5-diphenyltetrazalium bromide\] (MTT) assay for determination of safe concentrations. Mexicanolide-type limonoids **2** and **3** exhibited stronger inhibitory activities (IC~50~ of NO produced **2**: 23.9 μM; **3**: 11.8 μM) than the positive control, [l]{.smallcaps}-NMMA (IC~50~ of NO produced 47.6 μM) without cytotoxicities ([Figure 4](#molecules-23-01778-f004){ref-type="fig"}). These results demonstrated that compounds **2** and **3** have potency as inhibitors of NO production. However, the effect of compounds **1** and **2** were inferior to gedunin type limonoids such as gedunin (IC~50~ of NO produced **2**: 4.6 μM), 6α-acetoxygedunin (IC~50~ 7.9 μM), 7-deacetoxy-7-hydroxygedunin (IC~50~ 8.7 μM), and 6α-acetoxy-7α-deacetoxy-7α-hydroxygedunin (IC~50~ 9.4 μM) from the flower oil of *C. guianensis* \[[@B20-molecules-23-01778]\].

3. Experimental Section {#sec3-molecules-23-01778}
=======================

3.1. General Procedures {#sec3dot1-molecules-23-01778}
-----------------------

Melting points were determined on a Yanagimoto micro-melting point apparatus (YANAKO Measuring Instrument Trading Corporation, Kyoto, Japan) and were uncorrected. Optical rotations were measured using a JASCO DIP-1000 digital polarimeter (JASCO Corporation, Tokyo, Japan). IR spectra were recorded using a PerkinElmer 1720X FTIR spectrophotometer (PerkinElmer Japan Co. Ltd., Yokohama, Japan). All NMR experiments were measured with a Varian INOVA 600 spectrometer (Varian Medical Systems, Tokyo, Japan) with standard pulse sequences, operating at 600 and 150 MHz. CDCl~3~ was used as the solvent and Tetramethylsilane (TMS) as the internal standard. FABMS were recorded on a JEOL-7000 mass spectrometer (70 eV) (JEOL Ltd., Tokyo, Japan). Column chromatography (CC) was carried out on silica gel 60 (70--230 mesh) (Merck Chemicals B.V., Tokyo, Japan) and MPLC was carried out with silica gel (230--400 mesh) (Merck Chemicals B.V., Tokyo, Japan). HPLC was completed using a JASCO PU-1586 instrument (JASCO Corporation, Tokyo, Japan) equipped with a differential refractometer (RI 1531). Fractions obtained from column chromatography were monitored by thin-layer chromatography (TLC) (silica gel 60 F~254~) (Merck Chemicals B.V., Tokyo, Japan).

3.2. Plant Material {#sec3dot2-molecules-23-01778}
-------------------

The seed oil (2.03 kg) of Andiroba (*Carapa guianensis* A~ublet~, Meliaceae) was collected in the Amazon, Brazil, in March, 2013. It was kindly provided by Mr. Akira Yoshino (who is a representative person of the "NGO Green Heart love Amazon project"). A voucher specimen (CGS-01-2) was deposited in the Herbarium of the Laboratory of Medicinal Chemistry, Osaka University of Pharmaceutical Sciences.

3.3. Isolation of Compounds ***1**--**3*** {#sec3dot3-molecules-23-01778}
------------------------------------------

The seed oil of Andiroba (*Carapa guianensis* Aublet, Meliaceae) (2.03 kg) was dissolved in CHCl~3~, and the CHCl~3~ solution was subjected to CC (silica gel 14 kg), and affording 7 fractions: Fractions A (Fr. No. 1--76, 900 g), B (Fr. No. 77--110, 12.0 g), C (Fr. No. 111--125, 21.0 g), D (Fr. No. 126--155, 10.9 g), E (Fr. No. 156--170, 1.4 g), F (Fr. No. 171--180, 2.4 g), G (Fr. No. 181--195, 2.9 g), and H (Fr. No. 196--208, 0.7 g) \[[@B15-molecules-23-01778]\]. Fraction D was rechromatographed over a silica gel open-column (230--400 mesh, 200 g) eluted with *n*-hexane--AcOEt (1:1) to give eight fractions: D(1) (Fr. No. 1--35, 4.52 g), D(2) (Fr. No. 36--49, 1.81 g), D(3) (Fr. No. 50--88, 1.40 g), D(4) (Fr. No. 89--115, 0.93 g), D(5) (Fr. No. 116--130, 0.60 g), D(6) (Fr. No. 131--140, 0.52 g), D(7) (Fr. No. 141--205, 0.47 g), and D(8) (Fr. No. 206--215, 0.24 g). Fraction D(4) was subjected to a silica gel open-column (230--400 mesh, 100 g) eluted with *n*-hexane--EtOAc (3:1) to give an amorphous solid (34.1 mg) that was purified by HPLC (ODS, 75% MeOH) to give compounds **2** (6.2 mg, Retention time: 53.3 min.) and **3** (1.79 mg, Retention time: 52.5 min.). Fraction D(5) was subjected to a silica gel open-column (230--400 mesh, 60 g) eluted with *n*-hexane--EtOAc (3:1) to give an amorphous solid (24.0 mg) that was purified by HPLC (ODS, 75% MeOH) to give compound **1** (4.5 mg, Retention time: 42.8 min.).

3.4. Analytical Data {#sec3dot4-molecules-23-01778}
--------------------

Carapanosin D (**1**): Colorless amorphous solid; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{20}$ −9.5° (*c* = 0.1, EtOH); HRFABMS *m*/*z*: calcd. for C~37~H~44~O~16~, \[M + H\]^+^: 745.2693; found 745.2707; IR (KBr) ν~max~ cm^−1^; 2975, 1747(O--C=O), 1633; for ^1^H and ^13^C-NMR spectroscopic data, see [Table 1](#molecules-23-01778-t001){ref-type="table"}; FABMS *m*/*z* (rel. int.): 745 (100), \[M + H\]^+^, 685 \[M + H − HOAc\]^+^ (72), 449 (33).

Carapanosin E (**2**): Colorless amorphous solid; m.p. 96--98 °C; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{26}$ −25.8° (*c* 0.1, CHCl~3~); HRFABMS: *m*/*z* calcd for C~36~H~49~O~12~ \[M + H\]^+^: 673.3224; found 673.3224; UV λ~max~ (CH~3~CN) nm (log ε): 219 (3.76); IR (KBr) ν~max~ cm^−1^: 3489 (OH), 2974, 1727 (O--C=O), 1710 (six membered ring ketone), 1670 (αβ-unsaturated δ-lactone and 1461; for ^1^H and ^13^C-NMR spectroscopic data, see [Table 2](#molecules-23-01778-t002){ref-type="table"}; FABMS *m*/*z* (rel. int.): 673 (27) \[M + H\]^+^, 57 (100).

Carapanosin F (**3**): Colorless amorphous solid; m.p. 83--85 °C; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{26}$ +16.6° (*c* 0.1, CHCl~3~); HRFABMS *m*/*z* calcd. for C~37~H~49~O~12~ \[M + H\]^+^: 685.3224; found 685.3224; UV λ~max~ (CH~3~CN) nm (log ε): 232 (3.82), IR (KBr) ν~max~ cm^−1^: 3462 (OH), 2970, 1727 (O--C=O), 1707 (six membered ring ketone), 1670 (αβ-unsaturated δ-lactone), 1549, and 1461; for ^1^H and ^13^C-NMR spectroscopic data, see [Table 2](#molecules-23-01778-t002){ref-type="table"}; FABMS *m*/*z* (rel. int.): 685 (11) \[M + H\]^+^, 83 (100).

3.5. Cell Cultures {#sec3dot5-molecules-23-01778}
------------------

RAW264.7 cells (mouse macrophages) purchased from DS Pharma Biomedical Co., Ltd. (Osaka, Japan) were incubated in Dulbecco's Modified Eagle Medium (DMEM) containing 10% Fetal Bovine Serum (FBS) and antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin) in a 5% CO~2~ humidified incubator at 37 °C.

3.6. Determination of RAW264.7 Cell Proliferation {#sec3dot6-molecules-23-01778}
-------------------------------------------------

RAW264.7 cell proliferation was examined as described previously \[[@B13-molecules-23-01778]\].

3.7. Inhibitory Assay of NO Production {#sec3dot7-molecules-23-01778}
--------------------------------------

An inhibitory assay of nitric oxide production was performed as describe previously \[[@B13-molecules-23-01778]\].

4. Conclusions {#sec4-molecules-23-01778}
==============

A novel *nor*-phragmalin-type limonoid, named carapanosin D (**1**), and two new mexicanolide-type limonoids, named carapanosins E and F (**2**, **3**) were isolated from the seeds of *Carapa guianensis* (andiroba). Their structures were elucidated by extensive spectroscopic techniques. Carapanosin D (**1**) is the second example of 19-*nor*-phragmalin. Compounds **1**--**3** showed non-toxicities at 0--30 μM. Of these, compounds **2** and **3** showed superior inhibitory activities (IC~50~ of NO produced **2**: 23.9 μM; **3**: 11.8 μM) compared to the positive control, [l]{.smallcaps}-NMMA (IC~50~ of NO produced 47.6 μM). These results suggest that compounds **2** and **3** have high potency as inhibitors of macrophage activation.
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![Structures of compounds **1**--**3** from the seeds of *C. guianensis*.](molecules-23-01778-g001){#molecules-23-01778-f001}

![Key HMBC, COSY, and NOESY correlations of Carapanosin D (**1**).](molecules-23-01778-g002){#molecules-23-01778-f002}

![Key HMBC, COSY, and NOESY correlations of Carapanosin E (**2**).](molecules-23-01778-g003){#molecules-23-01778-f003}

![Inhibitory activities on nitic oxide (NO) production and cytotoxicities of Compounds **1**--**3** and N^G^-monomethyl-L-arginine acetate ([l]{.smallcaps}-NMMA). Each value represents the mean and the standard error (S.E.) of four determinations. Significant differences from the vehicle control (0 μM) group shown as: \* *p* \< 0.05 and \*\* *p* \< 0.01 in the NO inhibitory assay.](molecules-23-01778-g004){#molecules-23-01778-f004}

molecules-23-01778-t001_Table 1

###### 

^1^H- (600 MHz) and ^13^C- (150 MHz) NMR spectroscopic data of compound **1**.

  Position       1                                       Position                             1                                          
  ---------- --- --------------------------- ----------- ----------------------------- ------ --------- -------------------- ----------- -------------------
  1                                          84.6 (s)                                  18               1.23                 44.8 (q)    12, 13, 14, 17
  2                                          86.1 (s)                                  20                                    122.5 (s)   
  3              5.26 s                      80.6 (s)    4, 5, 28, 30, 1″              21               7.68 brd (0.9)       142.0 (s)   17, 20, 22
  4                                          44.6 (s)                                  22               6.40 dd (0.6, 1.7)   109.2 (d)   20, 23
  5              2.82 d (10.1)               38.2 (d)    1, 3, 4, 6, 7, 10, 29         23               7.37 t (1.7)         143.2 (d)   20, 22
  6          α   2.52 d (19.3)               30.0 (t)    4, 5, 7, 10                   28               0.98                 14.5 (q)    
             β   2.68 dd (10.1, 19.3)                                                  29     *pro-R*   1.91                 37.8 (t)    1, 2, 4, 5, 28
  7                                          174.2 (s)                                 29     *pro-S*   1.78                             
  8                                          85.3 (s)                                  30               5.94 s               68.7 (d)    1, 2, 3, 8, 9, 14
  9                                          84.0 (s)                                  31                                    119.4 (q)   
  10                                         86.4 (s)                                  32               1.71 s               20.6 (q)    
  11         α   1.82 m                      24.7 (t)    8, 9, 10, 12, 13              1′                                    170.1 (s)   
             β   1.84 m                                                                2′               2.15 s               21.6 (q)    1′
  12         α   1.05 ddd (1.4, 7.1, 14.4)   31.5 (t)    9, 11, 13, 14, 17             1″                                    169.6 (s)   
             β   1.11 (2.9, 4.7, 14.4)                                                 2″               2.30                 21.33 (q)   1″
  13                                         39.1 (s)                                  1″′              3.69 s               51.6 (q)    16
  14             2.36 dd (7.6, 16.5)         47.6 (d)    8, 13, 15, 16, 17, 18, 30     1″″                                   169.3 (s)   
  15         α   2.84 dd (4.1, 16.5)         30.4 (t)    8, 13, 14, 16                 2″″              1.96 s               21.26 (q)   1″″
             β   2.20 m                                                                1″″′                                  172.0 (s)   
  16                                         173.9 (s)                                 2″″′             2.26, 2.38           28.0 (t)    1″″′
  17             5.68 s                      69.8 (d)    12, 13, 14, 20, 21, 22, 1″″   3″″′             1.20 t (7.3)         21.3 (q)    1″″′

^a^ Measured at 600 MHz in CDCl~3~. ^b^ Measured at 150 MHz in CDCl~3~. Assignment are based on HMBC spectrum.

molecules-23-01778-t002_Table 2

###### 

^1^H and ^13^C-NMR spectroscopic data of compounds **2** and **3** (600 MHz, CDCl~3~, 150 MHz).

  Position       2                     3                                
  ---------- --- --------------------- ----------- -------------------- -----------
  1                                    204.1 (s)                        204.0 (s)
  2                                    86.3 (s)                         86.2 (s)
  3              5.15 s                79.7 (d)    5.14 s               80.4 (d)
  4                                    43.4 (s)                         43.6 (s)
  5              2.62 dd (6.7, 1.5)    38.6 (d)    2.68 t (1.0)         38.9 (d)
  6          α   2.45 dd (18.2, 1.5)   32.9 (t)    2.39 t (1.0)         32.9 (t)
             β   2.34 dd (18.2, 6.7)               2.46 t (1.0)         
  7                                    173.8 (s)                        173.9 (s)
  8                                    80.6 (s)                         80.4 (s)
  9              2.47 dd (12.9, 6.2)   65.7 (d)    2.45 m               65.4 (d)
  10                                   55.1 (s)                         55.7 (s)
  11         α   1.71 m                19.9 (t)    1.72 m               20.0 (t)
             β   1.50 m                            1.48 m               
  12         α   1.56 m                30.1 (t)    1.54 m               30.2 (t)
             β   1.76 m                            1.77 m               
  13                                   39.3 (s)                         39.3 (s)
  14                                   165.8 (s)                        166.0 (s)
  15             6.34 s                115.5 (d)   6.22 s               115.4 (d)
  16                                   164.9 (s)                        164.8 (s)
  17             5.44 s                78.9 (d)    5.43 s               78.9 (d)
  18             1.28 s                21.2 (q)    1.27 s               21.3 (q)
  19             1.09 s                18.8 (q)    1.09 s               18.8 (q)
  20                                   120.3 (s)                        120.3 (s)
  21             7.44 t (1.8)          141.6 (d)   7.45 dd (0.1, 0.2)   141.7 (d)
  22             6.47 dd (1.8, 0.9)    110.5 (d)   6.47 dd (0.1)        110.5 (d)
  23             7.45 d (0.9)          143.0 (d)   7.44 t (0.2)         143.0 (d)
  28             0.83 s                25.0 (q)    0.92 s               21.3 (q)
  29             0.91 s                21.4 (q)    0.86 s               25.5 (q)
  30             6.51 s                73.9 (d)    6.36 s               74.4 (d)
  1'                                   175.5 (s)                        166.2 (s)
  2'             2.86 sept (7.1)       34.3 (d)                         128.8 (s)
  3'             1.20 d (7.1)          18.1 (q)    6.88 q (7.1)         138.2 (d)
  4'             1.27 d (7.1)          19.8 (q)    1.91 d (7.1)         12.4 (q)
  5'                                               1.92 s               14.7 (q)
  1"             3.71 s                52.3 (q)    3.72 s               52.3 (q)
  1"'                                  174.4 (s)                        174.1 (s)
  2"'            2.43 m                40.8 (d)    2.39 m               40.7 (d)
  3"'        A   1.46 m                26.5 (t)    1.43 dq (1.3, 1.2)   26.5 (t)
             B   1.64 m                            1.60 dq (1.3, 1.2)   
  4"'            0.87 t (7.2)          11.4 (q)    0.84 t (7.1)         11.3 (q)
  5"'            1.12 d (7.2)          16.7 (q)    1.09 d (7.1)         16.7 (q)
  2-OH           4.08 s                            4.08 s               
  8-OH           2.84 s                            2.83 s               

^a^ Measured at 600 MHz in CDCl~3~. ^b^ Measured at 150 MHz in CDCl~3~. Assignments are based on HMBC spectrum.
